Resource Center for Stable Isotope-Resolved Metabolomics

稳定同位素解析代谢组学资源中心

• 批准号: 8620940
• 负责人: Teresa Whei-Mei Fan
• 金额: $ 190.01万
• 依托单位: UNIVERSITY OF KENTUCKY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-11 至 2018-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8620940
• 关键词: Address; Adoption; Algorithms; Animal Model; Animals; Arts; Award; Biochemical Pathway; Biomedical Research; Cardiovascular Diagnostic Techniques; Cell Culture Techniques; Cells; Client; Clinical Research; Communities; Consultations; Data; Data Analyses; Detection; Development; Devices; Diabetes Mellitus; Disease; Distance Learning; Education and Outreach; Educational workshop; Ensure; Experimental Designs; Fees; Foundations; Fractionation; Freezing; Fresh Tissue; Funding; Goals; Grant; Homeostasis; Human; Human Genome; Informatics; Infusion procedures; Instruction; International; Internet; Joints; Laboratories; Laboratory Research; Lead; Leadership; Learning; Malignant Neoplasms; Mass Spectrum Analysis; Metabolism; Methodology; Microfluidics; Modeling; Neurodegenerative Disorders; Outcome; Paper; Pathway interactions; Performance; Preparation; Procedures; Process; Proteome; Publications; Publishing; Qualifying; Regulation; Research; Research Personnel; Resected; Resource Informatics; Resources; Sampling; Services; Slice; Solid; Structure; System; Techniques; Technology; Therapeutic; Tissues; Tracer; Training; Training and Education; Transplantation; United States National Institutes of Health; Universities; Work; Xenograft procedure; base; bench to bedside; computerized data processing; cost; data acquisition; design; disease diagnosis; experience; handbook; human subject; instrumentation; meetings; metabolomics; network models; new therapeutic target; operation; outreach; prevent; programs; software development; stable isotope; symposium; tandem mass spectrometry; therapeutic development; ultra high resolution

DESCRIPTION: The human metabolome represents the functional display of the human genome and proteome. The regulation of its homeostasis is highly sensitive to both intrinsic and external factors, the perturbation of which can lead to disease development. Advances in mass spectrometry (MS), NMR, informatics, and sample processing have made possible large-scale interrogation of the human metabolome ("metabolomics") and is being increasingly applied to a variety of diseases, such as cancer, diabetes, neurodegenerative and cardiovascular disorders, for diagnosis and therapeutic purposes. The existing Center for Regulatory and Environmental Analytical Metabolomics (CREAM) conducts training and provides advice and full analytical resources, from sample processing, MS and NMR instrumentation, to informatics, which match with the major goals of the Common Fund. Moreover, CREAM is now in its 6th year of self- sufficiency through client fees and conducts translational clinical research, both of which are critical fifth-year exit goals of the Common Fund. Building on this solid foundation with added resources, the proposed Common Fund Regional Comprehensive Metabolomics Resource Core (RCMRC) at the University of Louisville will greatly expand CREAM's capabilities in sample processing, analytical/informatics developments and services, and outreach efforts under the leadership of the PD and Pis, who collectively have more than 95 years of experience in metabolomics. The Overall Goals of the RCMRC-CREAM are to facilitate and promote metabolomics research with an emphasis on stable isotope tracing for pathway elucidation in studies ranging from laboratory bench cell cultures, model animals, to human subjects, and to provide the state-of-art analytical and informatics resources, education, and training for the biomedical research community. These goals will be achieved via the following specific aims: SA1: To administer comprehensive Metabolomics resources for bench to bedside research; SA2: To develop and implement integrated Metabolomics platforms to enhance performance, sample & information throughput, and scientific relevance; SA3: To provide outreach and education of the wider community in Metabolomics approaches.

描述：人类代谢组代表了人类基因组和蛋白质组的功能展示。其稳态的调节对内在和外在因素都高度敏感，这些因素的干扰可导致疾病的发展。质谱法（MS）、NMR、信息学和样品处理的进步已经使得大规模询问人类代谢组（“代谢组学”）成为可能，并且正越来越多地应用于各种疾病，例如癌症、糖尿病、神经变性和心血管疾病，用于诊断和治疗目的。现有的监管和环境分析代谢组学中心（CREAM）开展培训，提供建议和完整的分析资源，从样品处理，MS和NMR仪器，到信息学，这与共同基金的主要目标相匹配。此外，CREAM现在已经通过客户费用自给自足6年，并进行转化临床研究，这两个目标都是共同基金的关键第五年退出目标。在这个坚实的基础上，通过增加资源，路易斯维尔大学拟议的共同基金区域综合代谢组学资源核心（RCMRC）将大大扩展CREAM在样品处理，分析/信息学开发和服务方面的能力，以及在PD和PI领导下的推广工作，他们在代谢组学方面拥有超过95年的经验。RCMRC-CREAM的总体目标是促进和促进代谢组学研究，重点是稳定同位素示踪，用于从实验室台细胞培养，模型动物到人类受试者的研究中的途径阐明，并为生物医学研究社区提供最先进的分析和信息学资源，教育和培训。这些目标将通过以下具体目标来实现：SA 1：管理全面的代谢组学资源，用于从实验室到床边的研究; SA 2：开发和实施综合代谢组学平台，以提高性能，样本和信息吞吐量以及科学相关性; SA 3：在代谢组学方法方面为更广泛的社区提供推广和教育。